Contacts, documents and full notice history are available with a subscription.
Presolicitation NONE Expired 1 notice

Maintenance Service for Illumina NextSeq™ 2000 Sequencer NIH-CC-OPC-25-007498

Solicitation NIH-CC-OPC-25-007498 Copied Notice ID 364faef260444370b8e20219d085d797 Copied HEALTH AND HUMAN SERVICES, DEPARTMENT OF — NATIONAL INSTITUTES OF HEALTH - CC
SAM.gov
Posted
Jul 10, 2025
Deadline
Jul 18, 2025
Set-aside
NONE
NAICS
811210
PSC
J049

Summary

AI-generated · Aug 26, 2025

Maintenance service contract for one Illumina NextSeq 2000 Sequencer, under the Illumina Silver Support Plan, including full parts, labor, and travel coverage; reagent replacement upon hardware failures; one preventive maintenance visit; remote technical support 18x5; average on-site response within two business days; software and hardware updates; on-site applications support; remote monitoring; and discounts on advanced training. The base period is 12 months from award date.

The award is intended as a sole-source, firm-fixed-price arrangement to Illumina, Inc. because Illumina is the sole manufacturer and the only known provider with access to performance-verified parts, software, and engineering resources needed to maintain the instrument to its original specifications; third-party sources are not available. While the process is described as sole-source under simplified acquisition procedures, the government may consider competition if credible capability statements are received. Interested firms may submit capability statements including basic company information and relevant codes for consideration.

This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested. The National Institute of Health, Clinical Center (CC) intends to award a Firm-Fixed price purchase order to Illumina, Inc., San Diego, CA 92122 on a sole source basis to provide maintenance service for one (1) Illumina NextSeq 2000 Sequencer. The instrument is used for to perform high-throughput, next-generation sequencing to diagnose inherited immune disorders within the Department of Lab Medicine. The requirements for the NextSeq 2000 Silver Support Plan include full coverage for parts, labor, and travel; Reagent replacement upon HW failures; 1 PM; Remote Technical Support 18x5; 2 business day average on-site response; control SW and HW updates; On-site applications support; discounts on advanced training; remote monitoring available. Illumina is the sole manufacturer and is the only known provider with access to performance verified component parts, spare parts, software, technical support, upgrades, and engineering resources to maintain the original operating specifications for the Illumina NextSeq 2000 Sequencer. The parts and services for this instrument are not available from third party sources. Only Illumina service engineers have the technical expertise and skills to troubleshoot and repair this instrument. Period of Performance shall be for a base year of twelve (12) months from date of award. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. The North American Industry Classification System (NAICS) code for this acquisition is 811210 with a large small business standard size of $34.0 million. This notice of intent to award is not a request for competitive quotations. Interested concerns capable of providing the same products or services as described in this notice may submit a capability statement outlining their capabilities. No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Each response should include the following Business Information: a. SAM UEI. b. Company Name, address, POC, Phone and Email address c. Current GSA Schedules or NAICS codes appropriate to this Award. d. Capability Statement Comments to this announcement may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Kimala Winfield, kimala.winfield@nih.gov or Malinda Dehner, dehnerm@cc.nih.gov by the due date and time marked in this notice.

From Presolicitation posted on Jul 10, 2025

Notice history

1
  1. Presolicitation LATEST Posted Jul 10, 2025

Details

Solicitation number NIH-CC-OPC-25-007498
Notice ID 364faef260444370b8e20219d085d797
Notice type Presolicitation
Product / Service (PSC) J049
NAICS 811210
Set-aside No Set aside used
Place of performance Bethesda, Maryland
Archive date Aug 02, 2025

Award Information

Not yet awarded

Documents

No files available

View on SAM.gov

Contacts

primary
Kimala Winfield

Email

Phone

secondary
Malinda Dehner

Email

Phone

Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF
NATIONAL INSTITUTES OF HEALTH
NATIONAL INSTITUTES OF HEALTH - CC

Place of Performance

Bethesda, Maryland 20892
USA

Dates

Posted Jul 10, 2025 1 year ago
Last Updated Aug 06, 2026 2 days ago
Due Jul 18, 2025 1 year ago